What is he best known for?
The fields of study he is best known for:
Ulrich Rodeck mainly investigates Cancer research, Epidermal growth factor, Cell biology, Growth factor and Molecular biology.
In his work, he performs multidisciplinary research in Cancer research and Acute lymphocytic leukemia.
His Epidermal growth factor research incorporates themes from A431 cells, In vitro, Growth factor receptor and Epidermal growth factor receptor.
His work in Cell biology addresses subjects such as Apoptosis, which are connected to disciplines such as Integrin, Extracellular matrix and Matrix.
His Growth factor research is multidisciplinary, incorporating perspectives in Endocrinology and Melanoma.
His studies in Molecular biology integrate themes in fields like Cell culture, Antigen, Receptor and Antibody, Monoclonal antibody.
His most cited work include:
- Zebrafish: an emerging model system for human disease and drug discovery. (322 citations)
- The EGF receptor - an essential regulator of multiple epidermal functions. (259 citations)
- Presence of Wilms' Tumor Gene (wt1) Transcripts and the WT1 Nuclear Protein in the Majority of Human Acute Leukemias (246 citations)
What are the main themes of his work throughout his whole career to date?
Ulrich Rodeck mostly deals with Cancer research, Cell biology, Molecular biology, Internal medicine and Epidermal growth factor.
His Cancer research research integrates issues from Cell culture, Autocrine signalling, Growth factor receptor and Epidermal growth factor receptor.
His Epidermal growth factor receptor study combines topics from a wide range of disciplines, such as Signal transduction and Immunology.
His Cell biology research includes elements of Programmed cell death, Zebrafish and Keratinocyte.
As part of the same scientific family, Ulrich Rodeck usually focuses on Molecular biology, concentrating on Monoclonal antibody and intersecting with Antigen and Epitope.
The Internal medicine study combines topics in areas such as Endocrinology and Oncology.
He most often published in these fields:
- Cancer research (38.27%)
- Cell biology (20.92%)
- Molecular biology (17.86%)
What were the highlights of his more recent work (between 2017-2021)?
- Head and neck squamous-cell carcinoma (7.65%)
- Oncology (7.65%)
- Internal medicine (15.82%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Head and neck squamous-cell carcinoma, Oncology, Internal medicine, Cancer research and Immune system.
The study incorporates disciplines such as T-stage, Lymph node, Pathology and Immunotherapy in addition to Head and neck squamous-cell carcinoma.
His work carried out in the field of Cancer research brings together such families of science as Tumor microenvironment, Cancer cell and Prostate cancer.
His study looks at the relationship between Immune system and topics such as Clinical trial, which overlap with Vector, Immunology and Cancer immunotherapy.
His Immune checkpoint study combines topics in areas such as Pyroptosis, Programmed cell death, Rational design, Dendritic cell and Melanoma.
His work focuses on many connections between Tumor progression and other disciplines, such as Cytokine, that overlap with his field of interest in Cell biology.
Between 2017 and 2021, his most popular works were:
- Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis (38 citations)
- Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. (27 citations)
- Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress. (26 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Cancer research, Head and neck squamous-cell carcinoma, Cancer, Immunotherapy and Tumor microenvironment.
His work deals with themes such as Cancer cell, RAD51, DNA repair and Adjuvant therapy, which intersect with Cancer research.
His biological study spans a wide range of topics, including Vector, Clinical trial and Immunology.
His Immunotherapy research includes themes of Immunohistochemistry, Macrophage and Lymph.
As a part of the same scientific family, Ulrich Rodeck mostly works in the field of Tumor microenvironment, focusing on FOXP3 and, on occasion, Papilloma, Primary tumor, Internal medicine, Tumor-infiltrating lymphocytes and Oncology.
The various areas that he examines in his T cell study include Dendritic cell, Melanoma and Programmed cell death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
